Saturday, February 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

XRP’s On-Chain Activity Plummets Despite Ripple’s Institutional Progress

SiterGedge by SiterGedge
February 21, 2026
in Banking & Insurance, Blockchain, Ethereum & Altcoins
0
XRP Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

A significant expansion of Deutsche Bank’s collaboration with Ripple Labs marks a milestone for the blockchain firm, highlighting growing institutional adoption of its technology. However, a closer examination reveals a critical divergence: the banking giant is implementing Ripple’s blockchain solutions but is not utilizing the XRP cryptocurrency within its operations. This distinction comes as activity on the XRP network itself experiences a severe contraction.

Network Engagement Crashes

Data from blockchain analyst Ali Martinez underscores a stark decline in user engagement on the XRP ledger. Over a seven-day period, the number of active addresses plummeted by approximately 26%, falling from 55,080 to 40,778. This sharp drop signals waning interest from retail participants and points to decreasing transaction volumes on the network. The positive news flow surrounding corporate partnerships is not reflected in the on-chain metrics, revealing a disconnect between institutional deals and ecosystem vitality.

Adoption Without the Asset

Deutsche Bank’s strategy focuses on leveraging Ripple’s enterprise-grade, blockchain-based software to modernize legacy payment infrastructures. The objectives are to reduce settlement times from days to seconds and to cut operational costs for cross-border transfers by up to 30%.

Should investors sell immediately? Or is it worth buying XRP?

Critically, this partnership utilizes Ripple’s private ledger technology and enterprise software suite. It does not employ the “On-Demand Liquidity” service, which specifically uses XRP as a bridge currency for liquidity. The bank is facilitating fiat-to-fiat transactions via blockchain rails, completely bypassing the need for the XRP token. For investors, this delineation is crucial—institutional acceptance of the underlying technology does not inherently translate into direct demand for the associated digital asset.

Price Feels the Strain

The growing chasm between technological adoption and token utility is applying downward pressure on XRP’s market valuation. The cryptocurrency has breached a key support level at $1.50 and is currently trading around $1.42. Market experts note that major financial institutions, including Standard Chartered, have revised their long-term price targets for XRP downward. This trend is viewed as evidence that the market is increasingly distinguishing between Ripple’s success as a software provider and the fundamental demand drivers for the XRP token.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from February 21 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 21.

XRP: Buy or sell? Read more here...

Tags: XRP
SiterGedge

SiterGedge

Related Posts

Beeline Holdings Stock
Analysis

Beeline Holdings Charts Aggressive Revenue Target with Strategic Hire

February 20, 2026
iShares MSCI Pacific ex Japan ETF Stock
Analysis

Pacific Ex-Japan ETF Approaches All-Time High

February 20, 2026
Coinbase Stock
Blockchain

Coinbase’s Billion-Dollar Buyback Provides Critical Share Price Support

February 20, 2026
Next Post
GRI Bio Stock

GRI Bio's Financial Runway Extends to 2027 Amid Clinical Push

Tilray Stock

Tilray Secures Exclusive U.S. Rights for Carlsberg Beer Portfolio

Ultragenyx Pharmaceutical Stock

Divergent Analyst Views Highlight Ultragenyx's Crossroads

Recommended

Powell Industries Stock

Powell Industries: A Study in Market Contradictions

6 months ago
Mastercard Stock

Mastercard Shares Approach Critical Juncture Amid Legal Settlement and Innovation Push

3 months ago
Tilray Stock

Tilray Shares Experience Dramatic Reversal Following Mixed Signals

4 months ago
The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

Intels Strategic Expansion Securing Government Grants for Military Chip Production and AI Development

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Escalating Dispute Threatens Barrick’s Strategic Reorganization Plans

Is StandardAero Stock Poised for a Valuation Reassessment?

Divergent Analyst Views Highlight Ultragenyx’s Crossroads

Tilray Secures Exclusive U.S. Rights for Carlsberg Beer Portfolio

GRI Bio’s Financial Runway Extends to 2027 Amid Clinical Push

XRP’s On-Chain Activity Plummets Despite Ripple’s Institutional Progress

Trending

BYD Stock
Analysis

A Legal Breakthrough and Strategic Moves Shape BYD’s Global Trajectory

by Kennethcix
February 21, 2026
0

While the Chinese electric vehicle titan BYD aggressively pursues market share across continents, a significant legal development...

Volatus Aerospace Stock

Volatus Aerospace Positioned for Growth Under Canada’s New Defense Policy

February 21, 2026
ImmunityBio Stock

ImmunityBio Gains Crucial European Market Access for Bladder Cancer Therapy

February 21, 2026
Barrick Mining Stock

Escalating Dispute Threatens Barrick’s Strategic Reorganization Plans

February 21, 2026
Standardaero Stock

Is StandardAero Stock Poised for a Valuation Reassessment?

February 21, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • A Legal Breakthrough and Strategic Moves Shape BYD’s Global Trajectory
  • Volatus Aerospace Positioned for Growth Under Canada’s New Defense Policy
  • ImmunityBio Gains Crucial European Market Access for Bladder Cancer Therapy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com